Advertisement
Screener

MiNK Therapeutics, Inc. (INKT) Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

1.7 / 5 stars · 11/32 Roast Me

MiNK Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

MiNK Therapeutics, Inc. (INKT) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$350.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-31

  • MiNK Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$350.00K.
  • MiNK Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was -$36.00K.
  • MiNK Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$397.00K, a 266.11% decline from fiscal 2022.
  • MiNK Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $239.00K.
Period endEffective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month
2025-12-31-$350.00K
10-K · filed 2026-03-31
2024-12-31-$36.00K
10-K · filed 2026-03-31
2023-12-31-$397.00K
10-K · filed 2025-03-18
2022-12-31$239.00K
10-K · filed 2024-03-21
2021-12-31-$9.00K
10-K · filed 2023-03-24
2020-12-31$2.00K
10-K · filed 2022-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73